India Clarithromycin Market to grow at Brisk rate through FY2026
Growing occurrence of
bacterial infections is expected to drive the growth of India clarithromycin
market during the forecast period.
According to
TechSci Research report, “India Clarithromycin Market By Application (Strep
throat, Pneumonia, Skin Infections, Respiratory Infections, Lyme Disease,
Helicobacter Pylori Infection, Others), By Form (Tablet, Capsule, Suspension,
Others), By Route of Administration (Oral vs Intravenous), By Source (In-house
v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s
Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast
& Opportunities, FY2026”, the India clarithromycin market
is expected to grow at a steady pace during the forecast period. This drug is primarily used for treatment of
ulcers caused by H. pylori which is known to affect larger population in the
country. Continuous research in applications of clarithromycin after FDA
approval for research activities and treatment is another major factor which is
expected to fuel the market growth through FY2026. However, side effects caused
due to drug consumption including diarrhea, nausea, abnormal taste, dyspepsia,
and abdominal discomfort can restrict the market growth over the next few
years. Moreover, limitation of drug usage by individuals that are suffering
from certain diseases and allergies to erythromycin is forecasted to further
reduce the usage and application of the drug thereby hindering the market growth
during the forecast period. Lack of awareness about the onset and risks of
bacterial infections among the population might act as a major impediment to
the market growth in the coming years.
Browse XX market data Tables and XX Figures spread
through XXX Pages and an in-depth TOC on " India Clarithromycin Market"
https://www.techsciresearch.com/report/india-clarithromycin-market/5156.html
The India
clarithromycin market is segmented based on application, form, route of
administration, source, distribution channel, end user, company, and
region. Based on source, the market can be categorized into in-house v/s
contract manufacturing organizations. The in-house segment dominated the market
until 2017 as most of the major market players focus on in house production
owing to the reduced dependency on suppliers. Additionally, in-house production
can provide fast and flexible response to market changes. This is further
expected to contribute to the segmental growth during the forecast period. Based
on end user, the market can be fragmented into adult v/s pediatric. Adult end
user segment dominated the market until 2017 and is expected to maintain its
dominance in the market during forecasted years as well on account of high
incidence of bacterial infections in adults.
Abbott India
Ltd., Novartis India Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo
Pharma Ltd., Teva API India Ltd., Wockhardt Limited, Taj Pharmaceuticals Ltd.,
Ajanta Pharma Ltd., Strides Pharma Science Ltd., Takeda Pharmaceuticals India
Private Ltd. and others are some of the leading players operating in India clarithromycin
market. Companies operating in the market are using organic strategies such as
product launches, mergers and acquisitions and collaborations to boost their
share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5156
Customers can
also request for 10% free customization on this report.
“India clarithromycin market
is expected to witness growth in the next 5 years which can be attributed to
the popularity of this drug among the individuals possessing penicillin allergy.
In addition to this increased count of skin and bacterial infections among the
population is further expected to create lucrative opportunities for the market
growth of India clarithromycin market over the next five years. Clarithromycin
drugs is also used to treat cancer which is forecasted to aid the growth of clarithromycin
market over the forthcoming years.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Clarithromycin Market By Application
(Strep throat, Pneumonia, Skin Infections, Respiratory Infections, Lyme
Disease, Helicobacter Pylori Infection, Others), By Form (Tablet, Capsule,
Suspension, Others), By Route of Administration (Oral vs Intravenous), By
Source (In-house v/s Contract Manufacturing Organizations), By Distribution
Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, has evaluated
the future growth potential of India clarithromycin market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in India clarithromycin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]